共2页/33条首页上一页12下一页尾页
回复:33 阅读:9530
Share my recent Pap-HPV research results with you

cqzhao 离线

帖子:5518
粉蓝豆:1071
经验:5755
注册时间:2008-09-29
加关注  |  发消息
楼主 发表于 2009-06-12 22:01|举报|关注(0)
浏览排序[ 顺序 逆序 楼主 支持 精彩 ]  快捷回复
标签:
本帖最后由 于 2009-06-12 22:06:00 编辑
0
添加参考诊断
×参考诊断
  

cqzhao 离线

帖子:5518
粉蓝豆:1071
经验:5755
注册时间:2008-09-29
加关注  |  发消息
21 楼    发表于2009-06-12 23:12:00举报|引用
返回顶部 | 快捷回复
  Cancer. 2007 Oct 25;111(5):292-7.

Very low Human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests.

Department of Pathology, Magee-Womens Hospital, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA. zhaoc@UPMC.edu

BACKGROUND: The prevalence of high-risk Human Papillomavirus DNA (hrHPV DNA) in women with negative Papanicolaou (Pap) test results provides a measure of residual risk for cervical neoplasia after cytology screening. The purpose of this study was to document the prevalence of hrHPV DNA in several thousand women ages > or =30 years with negative ThinPrep Imaging System (TIS)-imaged Pap test results in a large academic hospital cytology laboratory. METHODS: All cytology-negative TIS-imaged ThinPrep Pap tests (TPPT) with hrHPV DNA tests that were performed by the United States Food and Drug Administration (FDA)-approved Hybrid Capture 2 (HC2) method from May 1, 2005 to November 20, 2006 were identified and reviewed. Imaged-negative Pap test slides associated with a positive hrHPV DNA test result were rescreened manually. Variation in hrHPV DNA prevalence was assessed for different age and ethnic groups. RESULTS: Of 8070 imaged cytology-negative TPPT from women ages 11 to 90 years, hrHPV DNA test results were also available. Among 7426 women ages > or =30 years with a cytology-negative, TIS-imaged, Pap test, a significant age-associated decline in hrHPV DNA prevalence was noted, 3.4% in 3050 women ages 30-45 years, 2.4% in 7426 women ages 30-90 years, and 1.8% in 5491 women ages 40-90 years. The hrHPV DNA-positive rate was 2.3% in 6012 imaged cytology-negative white women and 4.1% in 739 imaged cytology-negative black women. CONCLUSIONS: Very low HC2 hrHPV DNA rates in 7426 women ages > or =30 years with cytology-negative, TIS-imaged, ThinPrep, Pap tests were similar to recently published data from 1 other academic center and lower than rates reported in previous studies on cytology-negative North American or European women screened manually with conventional or liquid-based Pap tests. These data may impact assessments of how best to combine cytology and HPV testing.

0
回复

cqzhao 离线

帖子:5518
粉蓝豆:1071
经验:5755
注册时间:2008-09-29
加关注  |  发消息
22 楼    发表于2009-06-12 23:14:00举报|引用
返回顶部 | 快捷回复
  Gynecol Oncol. 2007 Nov;107(2):231-5. Epub 2007 Sep 14.

Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone.

Department of Pathology, Magee-Womens Hospital, University of Pittsburgh Medical Center, 300 Halket Street, Pittsburgh, PA 15213-3180, USA.

OBJECTIVE: Sampling of the transformation zone (TZ) and endocervical cells (EC) has been widely regarded as a quality indicator in cervical screening programs; however, the significance of a TZ/EC sample (TZ/ECS) in promoting disease detection remains a matter of controversy. Because little data are available on the relationship between TZ/EC sampling and HPV DNA test results, we examined whether or not there is a measurable association between high-risk human papillomavirus (hrHPV) DNA test results and TZ/EC sampling in several thousand women screened in a large academic women's hospital laboratory. METHODS: 9035 ThinPrep Pap tests (TPPT) reported as negative, LSIL, or HSIL and which also had Hybrid capture 2 (HC2) hrHPV DNA testing over an 18 month period between July 1, 2005 and December 31, 2006 were documented. 8415 negative, 526 LSIL, and 84 HSIL TPPT were included in the study. The age of patients, the presence or absence of a TZ/ECS, and hrHPV DNA test results were noted from CoPath data files. Patients were stratified into 10 year age groups for data analysis. RESULTS: An identical 2.8% of Pap negative patients were hrHPV DNA positive in both the 6709 cytology negative patients with a TZ/ECS and the 1706 cytology negative patients without a TZ/ECS. Neither were statistically significant differences noted for hrHPV DNA prevalence in patients with SIL Pap test results from women with and without a TZ/ECS. CONCLUSIONS: HC2 hrHPV DNA detection in TPPT vials is independent of cytologic sampling of the transformation zone. hrHPV DNA results provide for the first time an available objective basis for risk assessment of patients with no TZ/ECS. The observation that hrHPV DNA test status is independent of presence or absence of a TZ/ECS is consistent with longitudinal studies of Pap negative women with no TZ/ECS which have not found increased disease on follow-up.

0
回复

cqzhao 离线

帖子:5518
粉蓝豆:1071
经验:5755
注册时间:2008-09-29
加关注  |  发消息
23 楼    发表于2009-06-12 23:19:00举报|引用
返回顶部 | 快捷回复

 CAP Nov. 2009 abstract (will work on paper soon)

Significance of hrHPV Testing in Women Age 50 Years or Older with LSIL and HSIL Cytology

Chengquan Zhao, MD (zhaoc@upmc.edu); Amer Heider, MD; R Mashall Austin, MD/PhD. Department of Pathology, Magee Womens Hospital, UPMC, Pittsburgh, Pa.

Abstract:
Context:
Older women are considered a “special population”. 2006 ASCCP Guidelines support reflex hrHPV testing as an option for postmenopausal women with LSIL. The data of hrHPV infection and its association to histologic CIN 2/3 in older women with LSIL and HSIL cytology are limited.
Design:
A computer-based search of Copath files of Magee-Womens Hospital, UPMC was carried out between July 1, 2005 and June 30, 2008 to retrieve women aged 50 years or above reported as LSIL or HSIL cytology who also were tested for hrHPV DNA (HC2). The HPV testing result, Pap and histologic follow up results were recorded.
Results:
hrHPV DNA was detected in 25 of 28 (89.3%) women age 50 or older with HSIL cytology, and in 154 of 217 (71.0%) women age 50 or older with LSIL cytology. The average interval between SIL cytology and an initial diagnosis of CIN 2/3 was 2.6 months (0 to 22 months) in women with HSIL cytology, and was 10.4 months (0-35 months) in women with LSIL cytology.The histologic findings are listed in the Table 1.
Histologic CIN Lesions between hrHPV Positive and Negative Testing Results in Older Women with LSIL and HSIL Cytology

hrHPV Positive hrHPV Negative
F/U No CIN 1
(%)
CIN 2
(%)
CIN 3
(%)
F/U No CIN 1
(%)
CIN 2
(%)
CIN 3
(%)
HSIL 21 2
(9.5)
9
(42.9)
10
(47.6)
3 0 1
(33.3)
1
(33.3)
LSIL 82 48
(58.5)
6
(7.3)
2
(2.4)
24 11
(45.8)
0 0

Conclusions:
The incidence of histologic CIN 2/3 was markedly higher in women with HSIL cytology than women with LSIL cytology. No CIN 2/3 was noted in older women with LSIL cytology and negative hrHPV testing. hrHPV testing might be helpful for risk assessment for older women with LSIL cytology, but not for older women with HSIL cytology.
:
0
回复

cqzhao 离线

帖子:5518
粉蓝豆:1071
经验:5755
注册时间:2008-09-29
加关注  |  发消息
24 楼    发表于2009-06-12 23:22:00举报|引用
返回顶部 | 快捷回复
 Abstract (will work on paper soon)

Histological Follow-up Findings in Adolescents with HSIL Cytology Results

Chengquan Zhao, MD Pal Kalposi-Novak, MD, R. Mashall Austin, MD, Dr.
Magee Womens Hospital, UPMC, Pittsburgh, PA, USA.

Abstract:
Introduction:
The incidence of cervical intraepithelial lesions is increased in adolescents and reflects the high prevalence of hrHPV infection in this special population. Recent follow-up guidelines emphasize conservative follow-up options. Furthermore, data from cohort studies suggest that regression of both low grade and high grade CIN are quite frequent in very young women. In this study we analyzed histological follow-up data for adolescent women who had HSIL cytology reports. We also assessed the effect of presence or absence of an adequate TZ/ECS in liquid-based Pap tests on the follow-up biopsy diagnoses.
Materials and methods:
The computerized records of a large academic women’s hospital were searched for cases reported as HSIL on TPPT in women age 20 or younger over a 6 year span between January 2002 and December, 2007. Histologic and Pap follow-up results, variations among age groups of adolescent women, and impact of presence or absence of TZ/ECS in Pap test were analyzed. Chi-Square test analysis was performed using SAS 9.1 System.
Results:
During the study period a total of 474 women age 20 or younger had HSIL Pap test results. 335 adolescent women with at least one cervical biopsy with or without endocervical curettage were included in the analysis. The average age was 18.6 years (13-20 years). The average follow-up period was 24 months (0 to 75 months) with a median of 22 months. The overall histologic CIN2/3 and detection rate was 44.2% and 47.8% for CIN1. The average period between the HSIL Pap test and an initial diagnosis of CIN2/3 was 5 months (0-62 months) with a median 2 months. The rates for histologic documentation of CIN in women age 19-20 compared to younger women were not statistically different. Detailed histologic findings are shown in Table 1. No invasive carcinomas or adenocarcinoma in situ cases were identified in this series of adolescents. The percentage of CIN 2/3 diagnosed on histologic follow up was not statistically significantly different when comparing women with and without a TZ/ECS in their preceding HSIL Pap tests (44.5% vs. 38.9%, p=0.642).
Conclusion:
Less than half of adolescent patients with HSIL cytology results had documented histologic CIN2/3 over an average follow-up period of 24 months, and no cases of invasive carcinoma were identified. CIN1 histologic follow-up findings were as common as CIN2/3 findings, likely reflecting both the increased likelihood of HSIL regression in younger women as well as the challenges of precise cytologic and histologic classification. High rates of hrHPV infection, only moderate rates of histologic CIN2/3 following HSIL cytology, and absence of invasive carcinoma all mark the adolescent group as a unique subset of patients deserving further study. Identification of additional biomarkers for HSIL progression would be useful.

Histologic Follow-up Finding in Adolescent Women with HSIL Cytology

Age (y)

F/U No

Negative (%)

CIN 1 (%)

CIN 2/3 (%)

19-20

199

13 (6.5)

94 (47.2)

92 (46.2)

<19

136

14 (10.3)

66 (48.5)

56 (41.2)

Total

335

27 (8.1)

160 (47.8)

148 (44.2)

0
回复

cqzhao 离线

帖子:5518
粉蓝豆:1071
经验:5755
注册时间:2008-09-29
加关注  |  发消息
25 楼    发表于2009-06-12 23:24:00举报|引用
返回顶部 | 快捷回复
 Abstract

The previous history of cytological and histological abnormalities among women with negative computer-imaged liquid-based Pap and positive HPV DNA test results

Anisa Kanbour, MD, Shuping Zhao, MD/PhD, Amal Kanbour-Shakir, MD/PhD, Chengquan Zhao Zhao, MD.
Magee Womens Hospital, UPMC, Pittsburgh, PA, USA.

Abstract:
Introduction:
No reports have documented the previous Pap test history for women with cytology negative- HPV positive testing results with methods of liquid-based cytology (LBC), computer-assisted screening, and HPV co-testing. The purpose of this study was to document the abnormal cytology and/or positive HPV testing results among women who tested hrHPV DNA positive along with negative computer-imaged liquid-based Pap co-test results.

Materials and methods:
The computerized hospital records of MWH were searched for patients reported as negative on ThinPrep Imaging System (TIS)-imaged ThinPrep Pap tests (TPPT) who also had positive Hybrid Capture 2 (HC2) hrHPV DNAwithPap co-test results between January 2008 and June 2008. The previous Pap cytology and HPV testing results for these women were analyzed. For women has two or more abnormal Pap tests or biopsy results, only the most abnormal diagnosis was recorded.

Results:
During the study period 202 women had negative TPPT and concurrent positive HC2 hrHPV DNA test results. 71 women showed no previous Pap tests and HPV testing in our files. 131 women had documented previous cytologic and/or HPV testing, or cervical biopsy results. Among these women, 55 (42%) showed normal Pap test and/or negative HPV testing history, 76 (58.0%) had at least one time of abnormal Pap tests or biopsy or Positive HPV testing results previously (Table 1).The interval between an initial abnormal Pap test and current positive HPV and negative TPPT findings ranged from 6 month to 13 years with average of 2.9 years. 71 of 76 cases (93.4%) had the first atypical Pap tests within 5 years.

Conclusion:
Our study indicates that more than half of the women (58%) with negative computer-imaged TPPT and positive HPV co-test results had previous abnormal Pap test or positive HPV testing history. HPV positivity predicts subsequent infection even though the risk of developing high grade dysplasia in women with negative Pap and positive HPV testing is very low. The previous Pap test, cervical biopsy, and HPV testing result should be considered for the risk assessment for cytology negative HPV positive women.

Cytologic and histologic abnormalities among 202 women with positive HPV tests and negative Pap test

Previous history

No.

%

No history

71

35.1

Negative

55

27.2

ASC-US

44

21.8

CIN 1/LSIL

24*

11.9

CIN 2

2

1.0

Pap-HPV+

6

3.0

Total HPV+

47

23.3

0
回复

cqzhao 离线

帖子:5518
粉蓝豆:1071
经验:5755
注册时间:2008-09-29
加关注  |  发消息
26 楼    发表于2009-06-12 23:26:00举报|引用
返回顶部 | 快捷回复

2008 USCAP abstract (is working for paper)

Follow-up outcomes of cytological and histological abnormalities among women with negative computer-imaged liquid-based Pap and positive HPV DNA test results

C Zhao, RM Austin

Department of Pathology, Magee-Womens Hospital (MWH) of University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

 

Background:

Limited data from the U.S. and overseas has been reported on the natural history of high risk(hr) HPV DNA positive women screened with negative conventional Pap smear results, but no reports have documented follow-up of cytology negative- HPV positive women routinely screened with newer methods of liquid-based cytology (LBC), computer-assisted screening, and HPV reflex or co-testing. The purpose of this study was to document the development of cytological and histological abnormalities among several hundred women who tested hrHPV DNA positive along with negative computer-imaged liquid-based Pap co-test results (DNAwithPap).  

Design:

The computerized hospital records of MWH were searched for patients reported as negative on ThinPrep Imaging System (TIS)-imaged ThinPrep Pap tests (TPPT) who also had positive Hybrid Capture 2 (HC2) hrHPV DNAwithPap co-test results over a 30 month span between July 2005 and December 2007. Cytologic and histologic follow-up outcomes were analyzed.

Results:

During the study period 402 women with negative TPPT and concurrent positive HC2 hrHPV DNA test results had documented cytologic and/or histologic follow-up. Histologic follow-up included 111 women who underwent cervical biopsy with or without ECC and 39 who underwent ECC alone. The mean age was 41.6 years (15-84 years). The average follow-up period was 13 months, ranging from 1 to 35 months (mean 10.6 m). Follow-up results documented that 8 of 402 (2.0%) women had tissue diagnoses of intraepithelial neoplasia 2+, including, four CIN2, 2 CIN3, one VAIN3, and one case of AIS on biopsy and microinvasive endocervical adenocarcinoma on subsequent conization. CIN1 or LSIL were confirmed in 61 (15.2%) and 82 (20.4%) had follow-up ASC-US Pap test results without biopsy findings of CIN1+. All CIN 2+ and 50 of 61 CIN 1 lesions were diagnosed based on histology. The interval between positive HPV and negative TPPT findings and an initial diagnosis of CIN 2+ ranged from 1 month to 19 months (median 14 months).

Conclusion:

CIN3, often proposed as a surrogate for invasive cervical cancer in cervical screening trials, was detected on initial follow-up (average 13 months) in 2 of 402 women (0.5%) with negative computer-imaged TPPT and positive HPV co-test results. Inclusion of two additional cases of histologically detected CIN2, one VAIN3, and one case of AIS with microinvasive endocervical adenocarcinoma potentially alters the risk profile of this cohort of over 400 cytology negative HPV positive patients. Additional natural history studies are needed on cytology negative HPV positive women routinely screened with modern methods which are now prevalent in the U.S. The potential benefits of routinely combining LBC and HPV co-testing for enhanced detection of endocervical neoplasia deserves special study, given the limited reported success of screening in this area to date.         

 

Table 1

Cytologic and histologic follow-up results among 402 women with positive HPV tests and negative Pap tests

Follow-up

No.

%

Negative

251

62.4

ASC-US

82

20.4

CIN 1/LSIL

61

15.2

CIN 2

4

1.0

CIN3

2

                           0.5

VAIN3/AIS

2

                           0.5

0
回复

cqzhao 离线

帖子:5518
粉蓝豆:1071
经验:5755
注册时间:2008-09-29
加关注  |  发消息
27 楼    发表于2009-06-12 23:30:00举报|引用
返回顶部 | 快捷回复

 Above are my Pap-HPV research results in the past three years. Wish our young pathologists can also do some research and summarize you data based on your situation.

Thank you for reading,

cz

0
回复

强子 离线

帖子:950
粉蓝豆:535
经验:1218
注册时间:2007-10-28
加关注  |  发消息
28 楼    发表于2009-06-13 07:16:00举报|引用
返回顶部 | 快捷回复
 赵老师是科研与临床两手抓两手都硬啊……
0
回复
signature
赚点散碎银子养家,乐呵呵的穿衣吃饭

雪莲 离线

帖子:370
粉蓝豆:5
经验:370
注册时间:2006-09-27
加关注  |  发消息
29 楼    发表于2009-06-13 12:03:00举报|引用
返回顶部 | 快捷回复
 高人也!
0
回复

青青子矜 离线

帖子:1387
粉蓝豆:12
经验:1387
注册时间:2007-11-23
加关注  |  发消息
30 楼    发表于2009-06-13 12:38:00举报|引用
返回顶部 | 快捷回复
 谢谢分享!这不仅开拓了我们的思路,对我们专业工作有指导作用,而且也锻炼了英文阅读能力,再次感谢无私奉献
0
回复

xiaogang 离线

帖子:5664
粉蓝豆:48
经验:6068
注册时间:2008-12-18
加关注  |  发消息
31 楼    发表于2009-06-13 14:03:00举报|引用
返回顶部 | 快捷回复
 Great
0
回复

cqzhao 离线

帖子:5518
粉蓝豆:1071
经验:5755
注册时间:2008-09-29
加关注  |  发消息
32 楼    发表于2009-06-27 19:46:00举报|引用
返回顶部 | 快捷回复
 

Thank laurelshihxbl for 翻译 of the AGC abstract:

verification bias:

Example: We perform Pap screening test with biopsy follow up. 10% women with LSIL Pap have or develope CIN 2/3. Then we conclude the risk of women with LSIL Pap for CIN 2/3 is 10%. However, women with normal Pap also can develop CIN 2/3 in study period. Rare studies can include a control group----to do the cervical biopsy for the women with negative Pap. True risk for LSIL-CIN 2/3 may be less than 10%.

This is called verification bias.

In fact the only study in which the control group of women with negative Pap had colposcopic examination was performed in Shanxi, China several years ago. This is called verification bias-adjusted.

In our AGC study, we added the data about hysterctomy specimens.  We calculated the AGC rate in all women with hysterectomy (cervical tissue were examined). This data avioided verification bias-----called verification bias- adjusted.

It is a very complicated concept. I am not sure if I explain it clearly.

0
回复

青青子矜 离线

帖子:1387
粉蓝豆:12
经验:1387
注册时间:2007-11-23
加关注  |  发消息
33 楼    发表于2009-11-14 22:32:00举报|引用
返回顶部 | 快捷回复
 学习,多谢!!
0
回复
回复:33 阅读:9530
共2页/33条首页上一页12下一页尾页
【免责声明】讨论内容仅作学术交流之用,不作为诊疗依据,由此而引起的法律问题作者及本站不承担任何责任。
快速回复
进入高级回复
您最多可输入10000个汉字,按 "Ctrl" + "Enter" 直接发送
搜索回复/乘电梯 ×
按内容
按会员
乘电梯
合作伙伴
友情链接